Dietary protein and blood glucose control

Current Opinion in Clinical Nutrition and Metabolic Care

Volumn 17, Issue 4, 2014, Pages 349-354

  Azzout Marniche, Dalila ^a   Gaudichon, Claire ^a   Tomé, Daniel ^a  

^a INRA Institut National de la Recherche Agronomique   (France)

Author keywords

Amino acid; Branched chain amino acid; Gluconeogenesis; Glucose; Insulin; Mammalian target of rapamycin; Protein; Type 2 diabetes

Indexed keywords

BRANCHED CHAIN AMINO ACID; GLUCOSE; INSULIN; LEUCINE; PROTEIN; AMINO ACID; GLUCOSE BLOOD LEVEL; PROTEIN INTAKE;

BLOOD GLUCOSE MONITORING; GLUCONEOGENESIS; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN LIKE ACTIVITY; INSULIN RELEASE; INSULIN RESISTANCE; INSULIN SENSITIVITY; NONHUMAN; PANCREAS ISLET BETA CELL; PROTEIN INTAKE; REVIEW; ANIMAL; BLOOD; DIABETES MELLITUS, TYPE 2; DISEASE MODEL; METABOLISM; POSTPRANDIAL STATE;

AMINO ACIDS; ANIMALS; BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 2; DIETARY PROTEINS; DISEASE MODELS, ANIMAL; HUMANS; INSULIN; INSULIN-SECRETING CELLS; POSTPRANDIAL PERIOD;

EID: 84902283611     PISSN: 13631950     EISSN: 14736519     Source Type: Journal    
DOI: 10.1097/MCO.0000000000000062     Document Type: Review

References (45)

1. El Khoury D, Hwalla N. Metabolic and appetite hormone responses of hyperinsulinemic normoglycemic males to meals with varied macronutrient compositions. Ann Nutr Metab 2010; 57:59-67.
2. Manders RJ, Little JP, Forbes SC, Candow DG. Insulinotropic and muscle protein synthetic effects of branched-chain amino acids: potential therapy for type 2 diabetes and sarcopenia. Nutrients 2012; 4:1664-1678.
3. Liu Z, Jeppesen PB, Gregersen S, et al. Dose-and glucose-dependent effects of amino acids on insulin secretion from isolated mouse islets and clonal INS-1E beta-cells. Rev Diabet Stud 2008; 5:232-244.
4. Salehi A, Gunnerud U, Muhammed SJ, et al. The insulinogenic effect of whey protein is partially mediated by a direct effect of amino acids and GIP on betacells. Nutr Metab 2012; 9:48.
5. Rorsman P, Braun M. Regulation of insulin secretion in human pancreatic islets. Annu Rev Physiol 2013; 75:155-179.
6. Salvucci M, Neufeld Z, Newsholme P. Mathematical model of metabolism and electrophysiology of amino acid and glucose stimulated insulin secretion: in vitro validation using a beta-cell line. PLoS One 2013; 8:e52611.
7. Krebs M, Brehm A, Krssak M, et al. Direct and indirect effects of amino acids on hepatic glucose metabolism in humans. Diabetologia 2003; 46:917-925.
8. Michaliszyn SF, Sjaarda LA, Mihalik SJ, et al. Metabolomic profiling of amino acids and beta-cell function relative to insulin sensitivity in youth. J Clin Endocrinol Metab 2012; 97:E2119-E2124.
9. Claessens M, Saris WH, van Baak MA. Glucagon and insulin responses after ingestion of different amounts of intact and hydrolysed proteins. Br J Nutr 2008; 100:61-69.
10. Power O, Hallihan A, Jakeman P. Human insulinotropic response to oral ingestion of native and hydrolysed whey protein. Amino acids 2009; 37:333-339.
11. Acheson KJ, Blondel-Lubrano A, Oguey-Araymon S, et al. Protein choices targeting thermogenesis and metabolism. Am J Clin Nutr 2011; 93:525-534.
12. Gunnerud UJ, Heinzle C, Holst JJ, et al. Effects of premeal drinks with protein and amino acids on glycemic and metabolic responses at a subsequent composite meal. PLoS One 2012; 7:e44731.
13. Manders RJ, Koopman R, Beelen M, et al. The muscle protein synthetic response to carbohydrate and protein ingestion is not impaired in men with longstanding type 2 diabetes. J Nutr 2008; 138:1079-1085.
14. Manders RJ, Koopman R, Sluijsmans WE, et al. Co-ingestion of a protein hydrolysate with or without additional leucine effectively reduces postprandial blood glucose excursions in type 2 diabetic men. J Nutr 2006; 136:1294-1299.
15. Manders RJ, Praet SF, Vikstrom MH, et al. Protein hydrolysate co-ingestion does not modulate 24 h glycemic control in long-standing type 2 diabetes patients. Eur J Clin Nutr 2009; 63:121-126.
16. Geerts BF, van Dongen MG, Flameling B, et al. Hydrolyzed casein decreases postprandial glucose concentrations in T2DM patients irrespective of leucine content. J Diet Suppl 2011; 8:280-292.
17. Azzout-Marniche D, Gaudichon C, Blouet C, et al. Liver glyconeogenesis: a pathway to cope with postprandial amino acid excess in high-protein fed rats? Am J Physiol Regul Integr Comp Physiol 2007; 292:R1400-1407.
18. Stepien M, Gaudichon C, Fromentin G, et al. Increasing protein at the expense of carbohydrate in the diet down-regulates glucose utilization as glucose sparing effect in rats. PLoS One 2011; 6:e14664.
19. Fromentin C, Azzout-Marniche D, Tome D, et al. The postprandial use of dietary amino acids as an energy substrate is delayed after the deamination process in rats adapted for 2 weeks to a high protein diet. Amino acids 2011; 40:1461-1472.
20. Nuttall FQ, Gannon MC. Dietary protein and the blood glucose concentration. Diabetes 2013; 62:1371-1372.
21. Fromentin C, Tome D, Nau F, et al. Dietary proteins contribute little to glucose production, even under optimal gluconeogenic conditions in healthy humans. Diabetes 2013; 62:1435-1442.
22. Nuttall FQ, Ngo A, Gannon MC. Regulation of hepatic glucose production and the role of gluconeogenesis in humans: is the rate of gluconeogenesis constant? Diabetes Metab Res Rev 2008; 24:438-458.
23. Tappy L, Acheson K, Normand S, et al. Effects of infused amino acids on glucose production and utilization in healthy human subjects. Am J Physiol 1992; 262:E826-E833.
24. Suhre K, Meisinger C, Doring A, et al. Metabolic footprint of diabetes: a multiplatform metabolomics study in an epidemiological setting. PLoS One 2010; 5:e13953.
25. Wang TJ, Larson MG, Vasan RS, et al. Metabolite profiles and the risk of developing diabetes. Nat Med 2011; 17:448-453.
26. Veldhorst MA, Westerterp-Plantenga MS, Westerterp KR. Gluconeogenesis and energy expenditure after a high-protein, carbohydrate-free diet. Am J Clin Nutr 2009; 90:519-526.
27. Smith TJ, Schwarz JM, Montain SJ, et al. High protein diet maintains glucose production during exercise-induced energy deficit: a controlled trial. Nutr Metab 2011; 8:26.
28. Newgard CB, An J, Bain JR, et al. A branched-chain amino acid-related metabolic signature that differentiates obese and lean humans and contributes to insulin resistance. Cell Metab 2009; 9:311-326.
29. Fiehn O, Garvey WT, Newman JW, et al. Plasma metabolomic profiles reflective of glucose homeostasis in nondiabetic and type 2 diabetic obese African-American women. PLoS One 2010; 5:e15234.
30. Gall WE, Beebe K, Lawton KA, et al. Alpha-hydroxybutyrate is an early biomarker of insulin resistance and glucose intolerance in a nondiabetic population. PLoS One 2010; 5:e10883.
31. Menni C, Fauman E, Erte I, et al. Biomarkers for type 2 diabetes and impaired fasting glucose using a nontargeted metabolomics approach. Diabetes 2013; 62:4270-4276.
32. McCormack SE, Shaham O, McCarthy MA, et al. Circulating branched-chain amino acid concentrations are associated with obesity and future insulin resistance in children and adolescents. Pediatr Obes 2013; 8:52-61.
33. Tai ES, Tan ML, Stevens RD, et al. Insulin resistance is associated with a metabolic profile of altered protein metabolism in Chinese and Asian-Indian men. Diabetologia 2010; 53:757-767.
34. Nagata C, Nakamura K, Wada K, et al. Branched-chain amino acid intake and the risk of diabetes in a Japanese community: The Takayama study. Am J Epidemiol 2013; 178:1226-1232.
35. Qin LQ, Xun P, Bujnowski D, et al. Higher branched-chain amino acid intake is associated with a lower prevalence of being overweight or obese in middleaged East Asian and Western adults. J Nutr 2011; 141:249-254.
36. Xiao F, Huang Z, Li H, et al. Leucine deprivation increases hepatic insulin sensitivity via GCN2/mTOR/S6K1 and AMPK pathways. Diabetes 2011; 60:746-756.
37. Li H, Lee J, He C, et al. Suppression of the mTORC1/STAT3/Notch1 pathway by activated AMPK prevents hepatic insulin resistance induced by excess amino acids. Am J Physiol Endocrinol Metab 2014; 306:E197-209.
38. Freudenberg A, Petzke KJ, Klaus S. Comparison of high-protein diets and leucine supplementation in the prevention of metabolic syndrome and related disorders in mice. J Nutr Biochem 2012; 23:1524-1530.
39. Zhang Y, Guo K, LeBlanc RE, et al. Increasing dietary leucine intake reduces diet-induced obesity and improves glucose and cholesterol metabolism in mice via multimechanisms. Diabetes 2007; 56:1647-1654.
40. Noguchi Y, Nishikata N, Shikata N, et al. Ketogenic essential amino acids modulate lipid synthetic pathways and prevent hepatic steatosis in mice. PLoS One 2010; 5:e12057.
41. Schwarz J, Tome D, Baars A, et al. Dietary protein affects gene expression and prevents lipid accumulation in the liver in mice. PLoS One 2012; 7:e47303.
42. Li T, Geng L, Chen X, et al. Branched-chain amino acids alleviate nonalcoholic steatohepatitis in rats. Appl Physiol Nutr Metab 2013; 38:836-843.
43. Li X, Wang X, Liu R, et al. Chronic leucine supplementation increases body weight and insulin sensitivity in rats on high-fat diet likely by promoting insulin signaling in insulin-Target tissues. Mol Nutr Food Res 2013; 57:1067-1079.
44. Binder E, Bermudez-Silva FJ, Andre C, et al. Leucine supplementation protects from insulin resistance by regulating adiposity levels. PLoS One 2013; 8:e74705.
45. Xu L, Kanasaki M, He J, et al. Ketogenic essential amino acids replacement diet ameliorated hepatosteatosis with altering autophagy-Associated molecules. Biochim Biophys Acta 2013; 1832:1605-1612.